Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03476954 · ClinicalTrials.gov registry record · NA
Perfusion Enhancement With Respiratory Impedance in Stroke (PERI-Stroke)
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03476954: Completed NA study, sponsored by University of Pennsylvania.
NCT03476954 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03476954, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a non-randomized phase 2 study designed to asses the mean flow velocity (MFV) and cerebral blood flow (CBF) response to non-invasive respiratory impedance.
Interventions
- OTHER Respiratory Impedance (RI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03476954
The ClinicalTrials.gov registry entry for NCT03476954 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Respiratory Impedance (RI) is the first listed.
NCT03476954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03476954 about?
NCT03476954 is a clinical study titled "Perfusion Enhancement With Respiratory Impedance in Stroke (PERI-Stroke)". This is a non-randomized phase 2 study designed to asses the mean flow velocity (MFV) and cerebral blood flow (CBF) response to non-invasive respiratory impedance.
What is the current status of trial NCT03476954?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-09. Estimated completion is 2017-03.
What interventions are being tested in trial NCT03476954?
The interventions under investigation include: Respiratory Impedance (RI) (OTHER).
Who is sponsoring clinical trial NCT03476954?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.